Trial description:
Phase III study assessing the "Best-Of" radiotherapy compared to the "Best-Of" surgery (trans-oral surgery (TOS) in patients with T1-T2, N0 oropharyngeal carcinoma
Contact name:
Dr Ekpemi Irune
Trial start date:
Tuesday, November 17, 2020
Trial end date:
Thursday, January 1, 2026
Trial tumour type:
Head & neck
Show on Radiotherapy:
Yes
